Brazil to help test Oxford’s Covid-19 vaccine
Team Udayavani, Jun 5, 2020, 3:02 PM IST
Brazil will soon start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford, supported by AstraZeneca
The vaccine will be tested in Brazil on 2,000 volunteers, who will be recruited starting this week.
Soraya Smaili, Brazilian university’s president, said, “Volunteers must be health professionals between 18 and 55 years old and be at high risk of infection, for example, cleaning and support staff in units treating Covid-19 patients”
Andrew Pollard, chief investigator of the Oxford Vaccine Trial at Oxford, said: “We are delighted to be working with the talented team of investigators in Brazil on the Covid-19 vaccine trial, as researchers and scientists around the world collaborate on clinical development work with unprecedented urgency to combat the global threat to human health that is coronavirus.”
The Oxford University vaccine, supported by AstraZeneca, is among the first Covid-19 vaccines to move into Phase II, or mid-stage, trials, along with one from the U.S. biotech company Moderna Inc
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates
MUST WATCH
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.